within Pharmacolibrary.Drugs.ATC.D;

model D06AX12
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 7.166666666666667e-05,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0161,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0148,
    k12             = 11.1,
    k21             = 11.1
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D06AX12</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Amikacin is an aminoglycoside antibiotic used primarily for the treatment of severe bacterial infections caused by Gram-negative bacteria, including those resistant to other aminoglycosides. It is approved and commonly used today, mainly in hospital settings for serious infections such as sepsis, pneumonia, urinary tract infections, and intra-abdominal infections.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult patients with normal renal function receiving intravenous infusion.</p><h4>References</h4><ol><li><p>Paegelow, JL, et al., &amp; Holbrook, TC (2024). Pharmacokinetics of amikacin after intravenous, intra-articular, and combined intravenous and intra-articular administration in healthy neonatal foals. <i>Journal of veterinary internal medicine</i> 38(3) 1825–1834. DOI:<a href=\"https://doi.org/10.1111/jvim.17087\">10.1111/jvim.17087</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38647141/\">https://pubmed.ncbi.nlm.nih.gov/38647141</a></p></li><li><p>Medellín-Garibay, SE, et al., &amp; García, B (2022). Amikacin pharmacokinetics in elderly patients with severe infections. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 175 106219–None. DOI:<a href=\"https://doi.org/10.1016/j.ejps.2022.106219\">10.1016/j.ejps.2022.106219</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35618200/\">https://pubmed.ncbi.nlm.nih.gov/35618200</a></p></li><li><p>Kilcoyne, I, et al., &amp; Nottle, BF (2023). Effects of a 10% dimethyl sulfoxide solution on radiocarpal joint amikacin pharmacokinetics during intravenous regional limb perfusion in standing sedated horses. <i>Veterinary surgery : VS</i> 52(8) 1171–1179. DOI:<a href=\"https://doi.org/10.1111/vsu.13973\">10.1111/vsu.13973</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37280731/\">https://pubmed.ncbi.nlm.nih.gov/37280731</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D06AX12;
